JP2013514345A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514345A5
JP2013514345A5 JP2012543942A JP2012543942A JP2013514345A5 JP 2013514345 A5 JP2013514345 A5 JP 2013514345A5 JP 2012543942 A JP2012543942 A JP 2012543942A JP 2012543942 A JP2012543942 A JP 2012543942A JP 2013514345 A5 JP2013514345 A5 JP 2013514345A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
optionally substituted
represented
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543942A
Other languages
English (en)
Japanese (ja)
Other versions
JP5793766B2 (ja
JP2013514345A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/055596 external-priority patent/WO2011073845A1/en
Publication of JP2013514345A publication Critical patent/JP2013514345A/ja
Publication of JP2013514345A5 publication Critical patent/JP2013514345A5/ja
Application granted granted Critical
Publication of JP5793766B2 publication Critical patent/JP5793766B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543942A 2009-12-16 2010-12-06 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体 Active JP5793766B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28703509P 2009-12-16 2009-12-16
US61/287,035 2009-12-16
PCT/IB2010/055596 WO2011073845A1 (en) 2009-12-16 2010-12-06 N-linked hydroxamic acid derivatives useful as antibacterial agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015142292A Division JP2016006064A (ja) 2009-12-16 2015-07-16 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体

Publications (3)

Publication Number Publication Date
JP2013514345A JP2013514345A (ja) 2013-04-25
JP2013514345A5 true JP2013514345A5 (enExample) 2014-02-06
JP5793766B2 JP5793766B2 (ja) 2015-10-14

Family

ID=43571291

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012543942A Active JP5793766B2 (ja) 2009-12-16 2010-12-06 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
JP2015142292A Pending JP2016006064A (ja) 2009-12-16 2015-07-16 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015142292A Pending JP2016006064A (ja) 2009-12-16 2015-07-16 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体

Country Status (10)

Country Link
US (4) US8664401B2 (enExample)
EP (1) EP2512474B1 (enExample)
JP (2) JP5793766B2 (enExample)
CA (2) CA2899583A1 (enExample)
DK (1) DK2512474T3 (enExample)
ES (1) ES2525820T3 (enExample)
PL (1) PL2512474T3 (enExample)
PT (1) PT2512474E (enExample)
SI (1) SI2512474T1 (enExample)
WO (1) WO2011073845A1 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2691987C (en) 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
US8722686B2 (en) 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
JP5793766B2 (ja) 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
US9738604B2 (en) 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
WO2012137094A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
WO2012137099A1 (en) * 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
WO2013170165A1 (en) * 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
WO2014072881A1 (en) * 2012-11-08 2014-05-15 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
WO2015024016A2 (en) 2013-08-16 2015-02-19 Duke University 2-piperidinyl substituted n,3-dihydroxybutanamides
AU2014306451B2 (en) 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
WO2015024011A2 (en) 2013-08-16 2015-02-19 Duke University Antibacterial compounds
US10112960B2 (en) 2013-09-05 2018-10-30 Dow Agrosciences Llc Methods for producing borylated arenes
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
EP2860177A3 (en) * 2013-09-20 2015-06-10 Bayer Intellectual Property GmbH Synthesis of functionalized arenes
KR20160098503A (ko) 2013-12-19 2016-08-18 액테리온 파마슈티칼 리미티드 항균성 1h-인다졸 및 1h-인돌 유도체
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
CN106573924B (zh) 2014-04-22 2019-06-25 诺华股份有限公司 作为LpxC抑制剂的异噁唑啉异羟肟酸衍生物
WO2015162518A1 (en) * 2014-04-25 2015-10-29 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
CA2946990A1 (en) 2014-04-28 2015-11-05 Pfizer Inc. Heterocyclic compounds and their use as dopamine d1 ligands
WO2015173329A1 (en) * 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
TW201625354A (zh) 2014-06-16 2016-07-16 陶氏農業科學公司 用於製備氧硼基化芳烴之方法
BR112017010474A2 (pt) 2014-11-19 2017-12-26 Actelion Pharmaceuticals Ltd derivados antibacterianos de benzotiazol
HUE047225T2 (hu) 2014-12-16 2020-04-28 Novartis Ag LpxC inhibitor izoxazol hidroxámsav-vegyületek
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
WO2017098440A1 (en) * 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Substituted benzazinones as antibacterial compounds
AU2017267194A1 (en) * 2016-05-17 2019-01-17 Idorsia Pharmaceuticals Ltd 6-(BUTA-1,3-DIYN-1-YL)benzo[D]thiazole derivatives
SMT202000524T1 (it) 2016-06-14 2020-11-10 Novartis Ag Forma cristallina di (r)-4-(5-(ciclopropiletinil)isossazol-3-il)-n-idrossi-2-metil-2-(metilsolfonil)butanammide come agente antibatterico
WO2017223349A1 (en) 2016-06-23 2017-12-28 Achaogen, Inc. Antibacterial agents
MX2019010302A (es) 2017-03-30 2019-11-21 Hoffmann La Roche Isoquinolinas como inhibidores de hpk1.
KR102868718B1 (ko) * 2018-02-10 2025-10-14 케이비피 바이오사이언시즈 씨오., 엘티디. 항생제로서 작용하는 화합물
CN111867600A (zh) * 2018-03-15 2020-10-30 辉瑞大药厂 用作抗菌剂的吡啶酮和嘧啶酮磷酸盐和硼酸盐
JP7386841B2 (ja) 2018-07-24 2023-11-27 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト イソキノリン化合物及びその使用
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
TW202023558A (zh) 2018-10-03 2020-07-01 美商建南德克公司 8-胺基異喹啉化合物及其用途
EP3946364B1 (en) * 2019-04-02 2025-11-19 Venatorx Pharmaceuticals, Inc. Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof
WO2023015236A2 (en) * 2021-08-04 2023-02-09 The Research Foundation For The State University Of New York Composition and method for treatment of gram negative bacterial infection
JP7874741B2 (ja) * 2022-03-30 2026-06-16 ゾエティス・サービシーズ・エルエルシー ＬｐｘＣ類似体の調製に有用な中間体、及びそれらの調製のためのプロセス

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995042A (en) * 1973-09-07 1976-11-30 E. R. Squibb & Sons, Inc. Pyridine containing compounds
US4769461A (en) 1986-09-16 1988-09-06 American Home Products Corporation Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
US5110831A (en) 1990-11-30 1992-05-05 Du Pont Merck Pharmaceutical Company Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
PL194240B1 (pl) 1998-02-07 2007-05-31 British Biotech Pharm Zastosowanie pochodnych N-formylohydroksyloaminy i amidowa pochodna N-formylohydroksyloaminy
GB9925470D0 (en) 1999-10-27 1999-12-29 Smithkline Beecham Plc Novel compounds
US6852752B2 (en) 1999-12-17 2005-02-08 Vicuron Pharmaceuticals Inc. Urea compounds, compositions and methods of use and preparation
WO2002074298A1 (en) 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Il-6 production inhibitors
ES2180456B1 (es) 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
ES2387803T3 (es) 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
GB0302431D0 (en) 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
EP1828145A4 (en) 2004-12-10 2009-08-19 Univ Emory 2'- AND 3'-SUBSTITUTED CYCLOBUTYL NUCLEOSIDE ANALOGUE FOR THE TREATMENT OF VIRAL INFECTIONS AND ANORMAL CELL PROLIFERATION
WO2006118155A1 (ja) 2005-04-27 2006-11-09 Ishihara Sangyo Kaisha, Ltd. ビフェニル誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤
WO2006124897A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
JP2009520695A (ja) * 2005-12-15 2009-05-28 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するｎ−ヒドロキシアミド誘導体
ES2331930T3 (es) 2006-02-14 2010-01-20 Pfizer Products Inc. Oxazolidinonas con benzoxazinonas y benzoxazepinonas como agentes antibacterianos.
WO2008045671A1 (en) 2006-10-06 2008-04-17 Janssen Pharmaceutica, N.V. Matrix metalloprotease inhibitors
CN101016270B (zh) 2006-12-30 2012-05-09 天津药物研究院 取代的哌嗪基苯基异噁唑啉衍生物及其用途
US7879911B2 (en) 2007-02-01 2011-02-01 Johnson Alan T Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
WO2008105515A1 (ja) 2007-02-28 2008-09-04 Taisho Pharmaceutical Co., Ltd. 新規なヒドロキサム酸誘導体
WO2008115262A2 (en) 2007-03-20 2008-09-25 Curis, Inc. Hsp90 inhibitors containing a zinc binding moiety
WO2010017060A1 (en) 2008-08-04 2010-02-11 Schering Corporation Urea derivatives as antibacterial agents
WO2010024356A1 (ja) 2008-08-27 2010-03-04 大正製薬株式会社 ナフチリジン－ｎ－オキシドを有する新規ヒドロキサム酸誘導体
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
US8722686B2 (en) 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
CA2774250C (en) * 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
JP5793766B2 (ja) 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
WO2012137094A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
WO2012137099A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents

Similar Documents

Publication Publication Date Title
JP2014507464A5 (enExample)
JP2013517281A5 (enExample)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2009534386A5 (enExample)
JP2014510132A5 (enExample)
JP2014525420A5 (enExample)
JP2014514299A5 (enExample)
NZ609955A (en) Sgc stimulators
JP2009528284A5 (enExample)
JP2011503118A5 (enExample)
JP2007517010A5 (enExample)
JP2013505969A5 (enExample)
PE20131118A1 (es) Derivados de heteroarilpiperidina y piperazina como fungicidas
JP2014504646A5 (enExample)
IN2012DN00573A (enExample)
JP2011500550A5 (enExample)
RU2009111113A (ru) Мидуляторы mglur5
JP2014517069A5 (enExample)
JP2013544276A5 (enExample)
JP2007523181A5 (enExample)
JP2010505809A5 (enExample)
JP2010526130A5 (enExample)
JP2011527666A5 (enExample)
JP2010511635A5 (enExample)
JP2013542980A5 (enExample)